• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌萎缩侧索硬化症(ALS)患者和动物模型的代谢功能障碍证据。

Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models.

机构信息

Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.

Translational Medicine Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.

出版信息

Biomolecules. 2023 May 19;13(5):863. doi: 10.3390/biom13050863.

DOI:10.3390/biom13050863
PMID:37238732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10216611/
Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects motor neurons, leading to muscle weakness, paralysis, and eventual death. Research from the past few decades has appreciated that ALS is not only a disease of the motor neurons but also a disease that involves systemic metabolic dysfunction. This review will examine the foundational research of understanding metabolic dysfunction in ALS and provide an overview of past and current studies in ALS patients and animal models, spanning from full systems to various metabolic organs. While ALS-affected muscle tissue exhibits elevated energy demand and a fuel preference switch from glycolysis to fatty acid oxidation, adipose tissue in ALS undergoes increased lipolysis. Dysfunctions in the liver and pancreas contribute to impaired glucose homeostasis and insulin secretion. The central nervous system (CNS) displays abnormal glucose regulation, mitochondrial dysfunction, and increased oxidative stress. Importantly, the hypothalamus, a brain region that controls whole-body metabolism, undergoes atrophy associated with pathological aggregates of TDP-43. This review will also cover past and present treatment options that target metabolic dysfunction in ALS and provide insights into the future of metabolism research in ALS.

摘要

肌萎缩侧索硬化症(ALS)是一种影响运动神经元的神经退行性疾病,导致肌肉无力、瘫痪,最终导致死亡。过去几十年的研究表明,ALS 不仅是运动神经元的疾病,而且还涉及全身代谢功能障碍。本综述将检查理解 ALS 中代谢功能障碍的基础研究,并概述 ALS 患者和动物模型的过去和当前研究,从整个系统到各种代谢器官。虽然 ALS 受累的肌肉组织表现出能量需求增加和燃料偏好从糖酵解转变为脂肪酸氧化的转变,但 ALS 中的脂肪组织经历脂肪分解增加。肝脏和胰腺的功能障碍导致葡萄糖稳态受损和胰岛素分泌受损。中枢神经系统(CNS)表现出异常的葡萄糖调节、线粒体功能障碍和氧化应激增加。重要的是,控制全身代谢的大脑区域下丘脑会发生与 TDP-43 病理性聚集相关的萎缩。本综述还将涵盖过去和现在针对 ALS 代谢功能障碍的治疗选择,并为 ALS 代谢研究的未来提供见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/10216611/f24916669d8f/biomolecules-13-00863-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/10216611/f24916669d8f/biomolecules-13-00863-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/10216611/f24916669d8f/biomolecules-13-00863-g001.jpg

相似文献

1
Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models.肌萎缩侧索硬化症(ALS)患者和动物模型的代谢功能障碍证据。
Biomolecules. 2023 May 19;13(5):863. doi: 10.3390/biom13050863.
2
Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症中的生物能量改变和代谢稳态失衡。
Neurotherapeutics. 2022 Jul;19(4):1102-1118. doi: 10.1007/s13311-022-01262-3. Epub 2022 Jun 30.
3
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?肌萎缩侧索硬化症中的中枢神经系统葡萄糖代谢:一个治疗靶点?
Cell Biosci. 2021 Jan 11;11(1):14. doi: 10.1186/s13578-020-00511-2.
4
AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症中的AMPK信号传导与能量代谢缺陷
Neurochem Res. 2016 Mar;41(3):544-53. doi: 10.1007/s11064-015-1665-3. Epub 2015 Jul 23.
5
Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments.肌萎缩侧索硬化症发病机制中的代谢功能障碍及潜在的代谢治疗方法
Front Neurosci. 2017 Jan 10;10:611. doi: 10.3389/fnins.2016.00611. eCollection 2016.
6
Integrative analysis of metabolomics and proteomics unravels purine metabolism dysregulation in the SOD1 mouse model of amyotrophic lateral sclerosis.代谢组学和蛋白质组学的综合分析揭示了肌萎缩侧索硬化症SOD1小鼠模型中的嘌呤代谢失调。
Neurobiol Dis. 2023 Jun 1;181:106110. doi: 10.1016/j.nbd.2023.106110. Epub 2023 Mar 29.
7
MicroRNA-183-5p regulates TAR DNA-binding protein 43 neurotoxicity via SQSTM1/p62 in amyotrophic lateral sclerosis.微小RNA-183-5p通过自噬受体蛋白在肌萎缩侧索硬化症中调节TAR DNA结合蛋白43的神经毒性
J Neurochem. 2023 Mar;164(5):643-657. doi: 10.1111/jnc.15744. Epub 2023 Jan 21.
8
Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: Proposed mechanisms and clinical implications.肌萎缩侧索硬化症中的血脑屏障功能障碍:拟议的机制和临床意义。
J Cereb Blood Flow Metab. 2023 May;43(5):642-654. doi: 10.1177/0271678X231153281. Epub 2023 Jan 26.
9
Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?骨骼肌代谢:肌萎缩侧索硬化症(ALS)发展的起源还是预后因素?
Cells. 2021 Jun 9;10(6):1449. doi: 10.3390/cells10061449.
10
Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS).瘦素信号在肌萎缩侧索硬化症(ALS)中的改变。
Int J Mol Sci. 2021 Sep 24;22(19):10305. doi: 10.3390/ijms221910305.

引用本文的文献

1
Multifaceted role of oxidative stress in neurological disorders.氧化应激在神经疾病中的多方面作用。
Mol Biol Rep. 2025 Jun 26;52(1):640. doi: 10.1007/s11033-025-10760-4.
2
Rhythmic TDP-43 affects RNA splicing of USP13, resulting in alteration of BMAL1 ubiquitination.节律性的TDP-43影响USP13的RNA剪接,导致BMAL1泛素化改变。
J Cell Biol. 2025 May 5;224(5). doi: 10.1083/jcb.202405142. Epub 2025 Apr 9.
3
Alterations of Fat and Ketone Body Metabolism in ALS and SMA-A Prospective Observational Study.肌萎缩侧索硬化症和脊髓性肌萎缩症中脂肪和酮体代谢的改变——一项前瞻性观察研究

本文引用的文献

1
Lipid catabolism and mitochondrial uncoupling are stimulated in brown adipose tissue of amyotrophic lateral sclerosis mouse models.在肌萎缩侧索硬化症小鼠模型的棕色脂肪组织中,脂质分解代谢和线粒体解偶联受到刺激。
Genes Dis. 2022 Apr 27;10(2):321-324. doi: 10.1016/j.gendis.2022.04.006. eCollection 2023 Mar.
2
Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine.解析 ALS 中的脂质失调:从机制到转化医学。
Transl Neurodegener. 2022 Nov 7;11(1):48. doi: 10.1186/s40035-022-00322-0.
3
Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis.
Eur J Neurol. 2025 Apr;32(4):e70132. doi: 10.1111/ene.70132.
4
Age-Related Neurodegenerative Diseases: A Stem Cell's Perspective.年龄相关性神经退行性疾病:干细胞视角
Cells. 2025 Feb 27;14(5):347. doi: 10.3390/cells14050347.
5
TMEM106B deficiency leads to alterations in lipid metabolism and obesity in the TDP-43 knock-in mouse model.在TDP-43基因敲入小鼠模型中,跨膜蛋白106B(TMEM106B)缺乏导致脂质代谢改变和肥胖。
Commun Biol. 2025 Feb 26;8(1):315. doi: 10.1038/s42003-025-07752-2.
6
Actual needs of patients with amyotrophic lateral sclerosis: a qualitative study from Wuhan, China.肌萎缩侧索硬化症患者的实际需求:来自中国武汉的一项定性研究。
BMC Palliat Care. 2025 Feb 22;24(1):50. doi: 10.1186/s12904-025-01684-8.
7
Associations of cachexia and frailty with amyotrophic lateral sclerosis.恶病质和衰弱与肌萎缩侧索硬化症的关联。
Sci Rep. 2025 Feb 5;15(1):4437. doi: 10.1038/s41598-025-89080-3.
8
Resting-State EEG Oscillations in Amyotrophic Lateral Sclerosis (ALS): Toward Mechanistic Insights and Clinical Markers.肌萎缩侧索硬化症(ALS)中的静息态脑电图振荡:寻求机制见解和临床标志物
J Clin Med. 2025 Jan 16;14(2):545. doi: 10.3390/jcm14020545.
9
Nutritional and Microbiota-Based Approaches in Amyotrophic Lateral Sclerosis: From Prevention to Treatment.肌萎缩侧索硬化症中基于营养和微生物群的方法:从预防到治疗
Nutrients. 2024 Dec 30;17(1):102. doi: 10.3390/nu17010102.
10
New perspectives of the role of skeletal muscle derived extracellular vesicles in the pathogenesis of amyotrophic lateral sclerosis: the 'dying back' hypothesis.骨骼肌衍生的细胞外囊泡在肌萎缩侧索硬化症发病机制中的作用新视角:“逆行性死亡”假说
J Extracell Biol. 2024 Nov 12;3(11):e70019. doi: 10.1002/jex2.70019. eCollection 2024 Nov.
下丘脑海体量随着体重指数降低与肌萎缩侧索硬化患者的生存时间更短相关。
Eur J Neurol. 2023 Jan;30(1):57-68. doi: 10.1111/ene.15589. Epub 2022 Nov 8.
4
Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者的体重和身体成分与疾病进展率的相关性。
Sci Rep. 2022 Aug 2;12(1):13292. doi: 10.1038/s41598-022-16229-9.
5
Lipid Metabolic Alterations in the ALS-FTD Spectrum of Disorders.肌萎缩侧索硬化症-额颞叶痴呆谱系障碍中的脂质代谢改变
Biomedicines. 2022 May 10;10(5):1105. doi: 10.3390/biomedicines10051105.
6
Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis.肌酸激酶与肌萎缩侧索硬化症预后的关系:文献综述与多中心队列分析。
J Neurol. 2022 Oct;269(10):5395-5404. doi: 10.1007/s00415-022-11195-8. Epub 2022 May 25.
7
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial.苯丁酸钠/牛磺熊去氧胆酸对肌萎缩侧索硬化症患者气管切开/无通气生存期及住院情况的影响:CENTAUR试验的长期结果
J Neurol Neurosurg Psychiatry. 2022 May 16;93(8):871-5. doi: 10.1136/jnnp-2022-329024.
8
TDP-43 regulates cholesterol biosynthesis by inhibiting sterol regulatory element-binding protein 2.TDP-43 通过抑制固醇调节元件结合蛋白 2 来调节胆固醇生物合成。
Sci Rep. 2022 May 14;12(1):7988. doi: 10.1038/s41598-022-12133-4.
9
Low-level overexpression of wild type TDP-43 causes late-onset, progressive neurodegeneration and paralysis in mice.野生型TDP-43的低水平过表达会导致小鼠迟发性进行性神经变性和麻痹。
PLoS One. 2022 Feb 3;17(2):e0255710. doi: 10.1371/journal.pone.0255710. eCollection 2022.
10
Body composition in amyotrophic lateral sclerosis subjects and its effect on disease progression and survival.肌萎缩侧索硬化症患者的身体成分及其对疾病进展和生存的影响。
Am J Clin Nutr. 2022 May 1;115(5):1378-1392. doi: 10.1093/ajcn/nqac016.